- Home
- NMHI vs ALBT Comparison
NMHI vs ALBT Comparison
Compare NMHI & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMHI
- ALBT
- Stock Information
- Founded
- NMHI N/A
- ALBT 2014
- Country
- NMHI United States
- ALBT United States
- Employees
- NMHI N/A
- ALBT N/A
- Industry
- NMHI
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMHI
- ALBT Health Care
- Exchange
- NMHI NYSE
- ALBT Nasdaq
- Market Cap
- NMHI 2.7M
- ALBT 3.2M
- IPO Year
- NMHI N/A
- ALBT N/A
- Fundamental
- Price
- NMHI $0.10
- ALBT $3.15
- Analyst Decision
- NMHI
- ALBT
- Analyst Count
- NMHI 0
- ALBT 0
- Target Price
- NMHI N/A
- ALBT N/A
- AVG Volume (30 Days)
- NMHI 100.2M
- ALBT 2.0M
- Earning Date
- NMHI 11-14-2024
- ALBT 11-12-2024
- Dividend Yield
- NMHI N/A
- ALBT N/A
- EPS Growth
- NMHI N/A
- ALBT N/A
- EPS
- NMHI N/A
- ALBT N/A
- Revenue
- NMHI $9,994,275.00
- ALBT N/A
- Revenue This Year
- NMHI N/A
- ALBT N/A
- Revenue Next Year
- NMHI N/A
- ALBT N/A
- P/E Ratio
- NMHI N/A
- ALBT N/A
- Revenue Growth
- NMHI N/A
- ALBT N/A
- 52 Week Low
- NMHI $0.08
- ALBT $2.11
- 52 Week High
- NMHI $11.40
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- NMHI 43.37
- ALBT 49.01
- Support Level
- NMHI $0.08
- ALBT $2.97
- Resistance Level
- NMHI $0.23
- ALBT $3.69
- Average True Range (ATR)
- NMHI 0.05
- ALBT 0.50
- MACD
- NMHI 0.00
- ALBT 0.01
- Stochastic Oscillator
- NMHI 4.94
- ALBT 40.31
About NMHI NATURES MIRACLE HLDG INC
Nature's Miracle Holding Inc is a growing agriculture technology company providing Controlled Environment Agriculture (CEA) hardware products to growers in the CEA industry setting in North America. It provides hardware to design, build, and operate various indoor growing settings, including greenhouse and indoor growing spaces. Its products include Horticultural Lighting, Irrigation System, Power Distribution Systems, Climate Control Systems, Disinfection Systems, and Materials And Equipment.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.